Log In
Print this Print this

BritLofex, lofexidine

  Manage Alerts
Collapse Summary General Information
Company Stada Arzneimittel AG
DescriptionAdrenergic receptor alpha 2 (ADRA2) agonist
Molecular Target Adrenergic receptor alpha 2 (ADRA2)
Mechanism of ActionAdrenergic receptor alpha 2 (ADRA2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsTreat addiction; Treat opiate withdrawal symptoms
Regulatory Designation
PartnerUS WorldMeds LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today